AnaptysBio, Inc. (ANAB)
45.95
-0.26
(-0.56%)
USD |
NASDAQ |
Oct 09, 16:00
46.00
+0.05
(+0.11%)
After-Hours: 20:00
AnaptysBio Price : 45.95 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 46.11 | 47.19 | 45.81 | 45.95 | 495669.0 |
| Oct 08, 2026 | 45.36 | 46.77 | 44.74 | 46.21 | 554155.0 |
| Oct 07, 2026 | 47.00 | 47.39 | 45.62 | 45.65 | 766532.0 |
| Oct 06, 2026 | 49.41 | 49.41 | 47.35 | 47.89 | 627091.0 |
| Oct 05, 2026 | 48.53 | 49.84 | 47.52 | 49.20 | 595547.0 |
| Oct 02, 2026 | 48.97 | 49.83 | 48.28 | 48.53 | 441125.0 |
| Oct 01, 2026 | 49.94 | 50.98 | 48.13 | 48.63 | 512335.0 |
| Sep 30, 2026 | 50.13 | 52.02 | 49.39 | 50.26 | 1.430M |
| Sep 29, 2026 | 50.44 | 50.90 | 49.46 | 50.37 | 677615.0 |
| Sep 28, 2026 | 51.00 | 51.65 | 50.50 | 50.80 | 412660.0 |
| Sep 25, 2026 | 52.38 | 52.38 | 50.80 | 51.00 | 437677.0 |
| Sep 24, 2026 | 50.59 | 52.16 | 50.35 | 51.70 | 418398.0 |
| Sep 23, 2026 | 53.55 | 53.93 | 49.45 | 50.77 | 779608.0 |
| Sep 22, 2026 | 55.07 | 56.04 | 50.61 | 53.92 | 755772.0 |
| Sep 21, 2026 | 56.00 | 56.00 | 54.09 | 54.92 | 525048.0 |
| Sep 18, 2026 | 55.76 | 55.77 | 53.71 | 55.20 | 868845.0 |
| Sep 17, 2026 | 55.09 | 55.79 | 54.49 | 55.06 | 439572.0 |
| Sep 16, 2026 | 54.44 | 54.80 | 53.62 | 54.31 | 394072.0 |
| Sep 15, 2026 | 54.28 | 55.32 | 53.22 | 54.68 | 351772.0 |
| Sep 14, 2026 | 54.58 | 55.70 | 54.00 | 54.11 | 436877.0 |
| Sep 11, 2026 | 55.43 | 56.32 | 53.75 | 53.87 | 336187.0 |
| Sep 10, 2026 | 55.43 | 56.43 | 54.31 | 55.16 | 300155.0 |
| Sep 09, 2026 | 55.59 | 57.89 | 55.25 | 55.70 | 295685.0 |
| Sep 08, 2026 | 55.48 | 58.16 | 54.79 | 56.60 | 1.036M |
| Sep 04, 2026 | 56.84 | 58.77 | 56.10 | 56.80 | 1.062M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 414.87 |
| Anika Therapeutics, Inc. | 19.58 |
| BioCryst Pharmaceuticals, Inc. | 8.55 |
| Imunon, Inc. | 1.08 |
Price Related Metrics
| PE Ratio | 7.129 |
| PS Ratio | 5.742 |
| Price to Book Value | 129.05 |
| Price to Free Cash Flow | 75.52 |
| Earnings Yield | 14.03% |
| Market Cap | 1.366B |
| Operating PE Ratio | 10.19 |
| Normalized PE Ratio | 7.128 |